HOLX News and Press, Hologic Inc. From 04/25/19

Company expands breast specimen imaging portfolio and leadership in breast cancer diagnosis and care Hologic, Inc. (Nasdaq: HOLX) today announced global commercial availability of the Trident ® HD specimen radiography system, a next-generation solution that delivers enhanced ima...

Cynosure launches “Be strong. Be sexy. Be confident.” campaign offering consumers the chance to meet the Hollywood icon and win free SculpSure ® treatments Hologic’s (Nasdaq: HOLX ) Cynosure division announced today that iconic actress, model, Broadway ...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2019 on Wednesday, May 1, 2019, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern...

Proposed rule highlights the risks of breast density and emphasizes important advances in mammography technology, including 3D mammography Hologic, Inc. (Nasdaq: HOLX), the world leader in breast cancer screening technology and the company behind the Genius™ 3D Mammography™...

Women’s health company offers new training facility for partners, healthcare professionals and employees Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company focused on improving women’s health and well-being through early detection and treatment, today...

The following slide deck was published by Hologic, Inc. in conjunction with this Read more ...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Cowen and Company 39 th Annual Healthcare Conference in Boston, MA on Tuesday, March 12 at 8:40 a.m. Eastern Time (ET). The Barclays Global Healthcare Conference ...

This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 02/14/2019. Please visit our Tracking Larry Robbins’ Glenview Capital Mana...

Hologic, Inc. (HOLX) Q1 2019 Earnings Conference Call January 30, 2019 4:30 PM ET Company Participants Mike Watts - Vice President, Investor Relations & Corporate Communications Steve MacMillan - Chairman, President & Chief Executive Officer Karleen Oberton - Chief Financ...

Hologic (NASDAQ: HOLX ) fiscal Q1 results ($M): Revenues: 830.7 (+5.0%); U.S. Breast Health: 252.6 (+12.6%). More news on: Hologic, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...